Cart
0

Polymerase Chain Reaction Technologies Market by Technology (Real-Time PCR, Traditional PCR, and Digital PCR), Product (Reagents & Consumables, Instruments, Software, and Services), Application (Clinical, Research, and Forensics), and End User (Diagnostic Centers & Hospitals, Biotech & Pharma Companies, and Academic & Research Institutions): Global Opportunity Analysis and Industry Forecast, 2017-2023

Get 20% Free Customization In This Report
LI_171625
Pages: 237
Dec 2017 | 2759 Views
 
Author's : Onkar Sumant and Tenzin Kunsel
Tables: 146
Charts: 37
 

Polymerase Chain Reaction Technologies Market Overview:

Global Polymerase Chain Reaction Technologies Market was valued at $7,027 million in 2016, and is estimated to reach $10,776 million by 2023, registering a CAGR of 6.2% from 2017 to 2023. Polymerase chain reaction technologies are medical devices used to generate thousands to millions of copies of a piece of deoxyribonucleic acid (DNA). These devices are commonly used in various life science fields such as genetics, molecular biology research, biotechnology, drug discovery, and clinical diagnostics. Moreover, these technologies are also used to identify criminals and child identity in forensics department. The device can also be used in the diagnosis of disease such as middle ear infections, tuberculosis, AIDS, and Lyme diseases. In academic field, polymerase chain reaction technologies are also used to identify cultures of microorganism that cause diseases.

Increase in the geriatric population, high prevalence of infectious diseases, rise in number of diagnostic centers and hospitals, technological advancements, and increase in awareness and acceptance of personalized medicine drives the polymerase chain reaction technologies market size. However, growth of non-validated home-brew test and reimbursement issues restraint the market growth. In addition, accurate and timely results for RT-PCR is a major challenge faced by the polymerase chain reaction technologies industry. Reduction in number of PCR processes makes the process less tedious and may open avenues of opportunities for the PCR market. Moreover, increase in funding for R&D activities and presence of untapped market in developing regions are expected to provide new avenues for the growth of polymerase chain reaction technologies market size in the near future.

Get more information on this report : Request Sample Pages

Technology Segment Review

In terms of technology, polymerase chain reaction technologies market is segmented into real-time PCR, traditional PCR, and digital PCR. Real-time PCR accounted for the highest revenue in 2016, and is projected to maintain the trend throughout the forecast period. However, digital PCR is anticipated to be the fastest growing segment in the polymerase chain reaction technologies market during the forecast period.

Get more information on this report : Request Sample Pages

Product Segment Review

Based on product, polymerase chain reaction technologies market is classified into reagents & consumables, instruments, software, and services. Reagents & consumables accounted for the highest polymerase chain reaction technologies market share in 2016, and is projected to maintain the trend throughout the forecast period. However, software segment is expected to be the fastest growing segment in the polymerase chain reaction technologies market during the forecast period.

Global Polymerase Chain Reaction Technologies Market: Key geographic segment

The polymerase chain reaction technologies market is segmented into North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest polymerase chain reaction technologies market share in 2016, and is expected to retain its dominance throughout the forecast period. However, Asia-Pacific is expected to be the fastest growing segment that will contribute towards the growth of polymerase chain reaction technologies market.

Get more information on this report : Request Sample Pages

Key players operating in the polymerase chain reaction technologies market are Thermo Fisher Scientific Inc., Sygnis AG, LGC Ltd, Bio-Rad Laboratories Inc., Agilent Technologies, Inc., BioMerieux S.A., RainDance Technologies, Inc., Affymetrix Inc., Fluidigm Corporation, and Takara Bio Inc.

Other prominent players in the value chain that operate in the polymerase chain reaction technologies market include Beckman Coulter, Becton, Dickinson and Company, Cepheid, Clontech Laboratories, Eppendorf, Fluidigm, GE Healthcare, Kapa Biosystems, Maxim Biotech, PerkinElmer, Promega, and Siemens Healthcare.

Key Benefits for Stakeholders

  • This report entails a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities.
  • Market estimations are based on comprehensive analysis of the key developments in the industry.
  • The global market is comprehensively analyzed with respect to technology, product, end user, application, and geography.
  • In-depth analysis based on geography assists in understanding the regional market to assist in strategic business planning.
  • The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.

Polymerase Chain Reaction Technologies Market Key Segments:

By Technology

  • Real-time PCR
  • Traditional PCR
  • Digital PCR

By Product

  • Reagents & Consumables
  • Instruments
  • Software
  • Services

By Application

  • Clinical
  • Research
  • Forensic

By End Users

  • Diagnostic Centers & Hospitals
  • Biotech & Pharma Companies
  • Academic & Research Institutions

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Taiwan
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA
 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top Winning Strategies
3.2.2. Top investment pockets, 2016

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. GOVERNMENT REGULATIONS

3.5.1. U.S. FDA
3.5.2. Europe- CE Mark and European Medicines Agency (EMA)
3.5.3. Ministry of Health, Labour, and Welfare (MHLW) and Japanese Pharmaceuticals and Medical Devices Agency (PMDA)

3.6. MARKET DYNAMICS

3.6.1. Drivers

3.6.1.1. Rise in prevalence of infectious diseases and cancer
3.6.1.2. Increase in awareness and acceptance of personalized medicines
3.6.1.3. Technological Advancements

3.6.2. Restraints

3.6.2.1. Growth of non-validated home brew test
3.6.2.2. Reimbursement issues

3.6.3. Opportunities

3.6.3.1. Increase in funding for R&D activities
3.6.3.2. Untapped markets in developing economies

Chapter: 4 POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY TECHNOLOGY

4.1. OVERVIEW

4.1.1. Market Size and Forecast

4.2. REAL-TIME PCR

4.2.1. Key Market Trends and Opportunities
4.2.2. Market Size and Forecast

4.3. TRADITIONAL PCR

4.3.1. Key Market Trends and Opportunities
4.3.2. Market Size and Forecast

4.4. DIGITAL PCR

4.4.1. Key Market Trends and Opportunities
4.4.2. Market Size and Forecast

Chapter: 5 POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY PRODUCT

5.1. OVERVIEW

5.1.1. Market Size and Forecast

5.2. REAGENTS & CONSUMABLES

5.2.1. Market Size and Forecast

5.3. INSTRUMENTS

5.3.1. Market Size and Forecast

5.4. SOFTWARE

5.4.1. Market Size and Forecast

5.5. SERVICES

5.5.1. Market Size and Forecast

Chapter: 6 POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY APPLICATION

6.1. OVERVIEW

6.1.1. Market Size and Forecast

6.2. CLINICAL

6.2.1. Market Size and Forecast

6.3. RESEARCH

6.3.1. Market Size and Forecast

6.4. FORENSICS

6.4.1. Market Size and Forecast

Chapter: 7 POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY END USERS

7.1. OVERVIEW

7.1.1. Market Size and Forecast

7.2. DIAGNOSTIC CENTERS & HOSPITALS

7.2.1. Market Size and Forecast

7.3. BIOTECH & PHARMA COMPANIES

7.3.1. Market Size and Forecast

7.4. ACADEMIC & RESEARCH INSTITUTIONS

7.4.1. Market Size and Forecast

Chapter: 8 POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY GEOGRAPHY

8.1. OVERVIEW

8.1.1. Market size and forecast

8.2. NORTH AMERICA

8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast by country
8.2.4. Market size and forecast by Technology
8.2.5. Market size and forecast by Product
8.2.6. Market size and forecast by Application
8.2.7. Market size and forecast by End Users

8.2.7.1. U.S. market size and forecast by Technology
8.2.7.2. U.S. market size and forecast by Product
8.2.7.3. U.S. market size and forecast by Application
8.2.7.4. U.S. market size and forecast by End Users
8.2.7.5. Canada market size and forecast by Technology
8.2.7.6. Canada market size and forecast by Product
8.2.7.7. Canada market size and forecast by Application
8.2.7.8. Canada market size and forecast by End Users
8.2.7.9. Mexico market size and forecast by Technology
8.2.7.10. Mexico market size and forecast by Product
8.2.7.11. Mexico market size and forecast by Application
8.2.7.12. Mexico market size and forecast by End Users

8.3. EUROPE

8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast by country
8.3.4. Market size and forecast by Technology
8.3.5. Market size and forecast by Product
8.3.6. Market size and forecast by Application
8.3.7. Market size and forecast by End Users

8.3.7.1. Germany market size and forecast by Technology
8.3.7.2. Germany market size and forecast by Product
8.3.7.3. Germany market size and forecast by Application
8.3.7.4. Germany market size and forecast by End Users
8.3.7.5. France market size and forecast by Technology
8.3.7.6. France market size and forecast by Product
8.3.7.7. France market size and forecast by Application
8.3.7.8. France market size and forecast by End Users
8.3.7.9. UK market size and forecast by Technology
8.3.7.10. UK market size and forecast by Product
8.3.7.11. UK market size and forecast by Application
8.3.7.12. UK market size and forecast by End Users
8.3.7.13. Italy market size and forecast by Technology
8.3.7.14. Italy market size and forecast by Product
8.3.7.15. Italy market size and forecast by Application
8.3.7.16. Italy market size and forecast by End Users
8.3.7.17. Spain market size and forecast by Technology
8.3.7.18. Spain market size and forecast by Product
8.3.7.19. Spain market size and forecast by Application
8.3.7.20. Spain market size and forecast by End Users
8.3.7.21. Rest of Europe market size and forecast by Technology
8.3.7.22. Rest of Europe market size and forecast by Product
8.3.7.23. Rest of Europe market size and forecast by Application
8.3.7.24. Rest of Europe market size and forecast by End Users

8.4. ASIA-PACIFIC

8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast by country
8.4.4. Market size and forecast by Technology
8.4.5. Market size and forecast by Product
8.4.6. Market size and forecast by Application
8.4.7. Market size and forecast by End Users

8.4.7.1. Japan market size and forecast by Technology
8.4.7.2. Japan market size and forecast by Product
8.4.7.3. Japan market size and forecast by Application
8.4.7.4. Japan market size and forecast by End Users
8.4.7.5. China market size and forecast by Technology
8.4.7.6. China market size and forecast by Product
8.4.7.7. China market size and forecast by Application
8.4.7.8. China market size and forecast by End Users
8.4.7.9. Australia market size and forecast by Technology
8.4.7.10. Australia market size and forecast by Product
8.4.7.11. Australia market size and forecast by Application
8.4.7.12. Australia market size and forecast by End Users
8.4.7.13. India market size and forecast by Technology
8.4.7.14. India market size and forecast by Product
8.4.7.15. India market size and forecast by Application
8.4.7.16. India market size and forecast by End Users
8.4.7.17. South Korea market size and forecast by Technology
8.4.7.18. South Korea market size and forecast by Product
8.4.7.19. South Korea market size and forecast by Application
8.4.7.20. South Korea market size and forecast by End Users
8.4.7.21. Taiwan market size and forecast by Technology
8.4.7.22. Taiwan market size and forecast by Product
8.4.7.23. Taiwan market size and forecast by Application
8.4.7.24. Taiwan market size and forecast by End Users
8.4.7.25. Rest of Asia-Pacific market size and forecast by Technology
8.4.7.26. Rest of Asia-Pacific market size and forecast by Product
8.4.7.27. Rest of Asia-Pacific market size and forecast by Application
8.4.7.28. Rest of Asia-Pacific market size and forecast by End Users

8.5. LAMEA

8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast by country
8.5.4. Market size and forecast by Technology
8.5.5. Market size and forecast by Product
8.5.6. Market size and forecast by Application
8.5.7. Market size and forecast by End Users

8.5.7.1. Brazil market size and forecast by Technology
8.5.7.2. Brazil market size and forecast by Product
8.5.7.3. Brazil market size and forecast by Application
8.5.7.4. Brazil market size and forecast by End Users
8.5.7.5. Saudi Arabia market size and forecast by Technology
8.5.7.6. Saudi Arabia market size and forecast by Product
8.5.7.7. Saudi Arabia market size and forecast by Application
8.5.7.8. Saudi Arabia market size and forecast by End Users
8.5.7.9. South Africa market size and forecast by Technology
8.5.7.10. South Africa market size and forecast by Product
8.5.7.11. South Africa market size and forecast by Application
8.5.7.12. South Africa market size and forecast by End Users
8.5.7.13. Rest of LAMEA market size and forecast by Technology
8.5.7.14. Rest of LAMEA market size and forecast by Product
8.5.7.15. Rest of LAMEA market size and forecast by Application
8.5.7.16. Rest of LAMEA market size and forecast by End Users

Chapter: 9 COMPANY PROFILES

9.1. AGILENT TECHNOLOGIES, INC.

9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio
9.1.5. Business performance
9.1.6. Key strategic moves and developments

9.2. BIOMERIEUX S.A.

9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product portfolio
9.2.5. Business performance
9.2.6. Key strategic moves and developments

9.3. BIO-RAD LABORATORIES, INC.

9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Product portfolio
9.3.5. Business performance
9.3.6. Key strategic moves and developments

9.4. F. HOFFMANN-LA ROCHE AG (ROCHE)

9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio
9.4.5. Business performance
9.4.6. Key strategic moves and developments

9.5. FLUIDIGM CORPORATION

9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio
9.5.5. Business performance
9.5.6. Key strategic moves and developments

9.6. LGC LIMITED

9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product portfolio
9.6.5. Key strategic moves and developments

9.7. QIAGEN N.V.

9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio
9.7.5. Business performance

9.8. SYGNIS AG

9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product portfolio
9.8.5. Business performance
9.8.6. Key strategic moves and developments

9.9. TAKARA BIO INC.

9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product portfolio
9.9.5. Business performance
9.9.6. Key strategic moves and developments

9.10. THERMO FISHER SCIENTIFIC INC.

9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product portfolio
9.10.5. Business performance
9.10.6. Key strategic moves and developments

LIST OF TABLES

TABLE 1. GLOBAL POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY TECHNOLOGY, 2016-2023, ($MILLION)
TABLE 2. REAL-TIME PCR POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET  BY GEOGRAPHY 2016-2023, ($MILLION)
TABLE 3. TRADITIONAL PCR POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY GEOGRAPHY 2016-2023, ($MILLION)
TABLE 4. DIGITAL PCR POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY GEOGRAPHY 2016-2023, ($MILLION)
TABLE 5. GLOBAL POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY PRODUCT, 2016-2023, ($MILLION)
TABLE 6. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET FOR REAGENTS & CONSUMABLES, BY GEOGRAPHY 2016-2023, ($MILLION)
TABLE 7. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET FOR INSTRUMENTS, BY GEOGRAPHY 2016-2023, ($MILLION)
TABLE 8. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET FOR SOFTWARE,  BY GEOGRAPHY 2016-2023, ($MILLION)
TABLE 9. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET FOR SERVICES,  BY GEOGRAPHY 2016-2023, ($MILLION)
TABLE 10. GLOBAL POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY APPLICATION, 2016-2023, ($MILLION)
TABLE 11. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET FOR CLINICAL APPLICATION, BY GEOGRAPHY 2016-2023, ($MILLION)
TABLE 12. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET FOR RESEARCH APPLICATION, BY GEOGRAPHY 2016-2023, ($MILLION)
TABLE 13. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET FOR FORENSIC APPLICATION, BY GEOGRAPHY 2016-2023, ($MILLION)
TABLE 14. GLOBAL POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY END USERS, 2016-2023, ($MILLION)
TABLE 15. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY DIAGNOSTIC CENTERS & HOSPITALS , BY GEOGRAPHY 2016-2023, ($MILLION)
TABLE 16. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY BIOTECH & PHARMA COMPANIES, BY GEOGRAPHY 2016-2023, ($MILLION)
TABLE 17. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY ACADEMIC & RESEARCH INSTITUTIONS, BY GEOGRAPHY 2016-2023, ($MILLION)
TABLE 18. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY REGION,  2016-2023 ($MILLION)
TABLE 19. NORTH AMERICA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY COUNTRY, 2016-2023 ($MILLION)
TABLE 22. NORTH AMERICA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY APPLICATION, 2016-2023 ($MILLION)
TABLE 23. NORTH AMERICA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY END USERS, 2016-2023 ($MILLION)
TABLE 24. U.S. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 26. U.S. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY APPLICATION, 2016-2023 ($MILLION)
TABLE 27. U.S. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 28. CANADA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 30. CANADA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY APPLICATION, 2016-2023 ($MILLION)
TABLE 31. CANADA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 32. MEXICO POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 34. MEXICO POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY APPLICATION, 2016-2023 ($MILLION)
TABLE 35. MEXICO POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 36. EUROPE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY COUNTRY, 2016-2023 ($MILLION)
TABLE 37. EUROPE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 38. EUROPE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY PRODUCT, 2016-2023 ($MILLION)
TABLE 39. EUROPE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY APPLICATION, 2016-2023 ($MILLION)
TABLE 40. EUROPE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 41. GERMANY POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 43. GERMANY POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 44. GERMANY POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 45. FRANCE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 47. FRANCE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY APPLICATION, 2016-2023 ($MILLION)
TABLE 48. FRANCE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 49. UK POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 51. UK POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 52. UK POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 53. ITALY POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 55. ITALY POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY APPLICATION, 2016-2023 ($MILLION)
TABLE 56. ITALY POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 57. SPAIN POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 59. SPAIN POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY APPLICATION, 2016-2023 ($MILLION)
TABLE 60. SPAIN POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 61. REST OF EUROPE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 63. REST OF EUROPE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY APPLICATION, 2016-2023 ($MILLION)
TABLE 64. REST OF EUROPE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY END USERS, 2016-2023 ($MILLION)
TABLE 65. ASIA-PACIFIC POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY COUNTRY, 2016-2023 ($MILLION)
TABLE 66. ASIA-PACIFIC POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 67. ASIA-PACIFIC POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY PRODUCT, 2016-2023 ($MILLION)
TABLE 68. ASIA-PACIFIC POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY APPLICATION, 2016-2023 ($MILLION)
TABLE 69. ASIA-PACIFIC POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY END USERS, 2016-2023 ($MILLION)
TABLE 70. JAPAN POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 72. JAPAN POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY APPLICATION, 2016-2023 ($MILLION)
TABLE 73. JAPAN POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 74. CHINA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 76. CHINA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY APPLICATION, 2016-2023 ($MILLION)
TABLE 77. CHINA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 78. AUSTRALIA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 80. AUSTRALIA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY APPLICATION, 2016-2023 ($MILLION)
TABLE 81. AUSTRALIA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 82. INDIA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 84. INDIA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY APPLICATION, 2016-2023 ($MILLION)
TABLE 85. INDIA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 86. SOUTH KOREA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 88. SOUTH KOREA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY APPLICATION, 2016-2023 ($MILLION)
TABLE 89. SOUTH KOREA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY END USERS, 2016-2023 ($MILLION)
TABLE 90. TAIWAN POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  “BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 92. TAIWAN POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY APPLICATION, 2016-2023 ($MILLION)
TABLE 93. TAIWAN POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 94. REST OF ASIA-PACIFIC POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 96. REST OF ASIA-PACIFIC POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 97. REST OF ASIA-PACIFIC POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 98. LAMEA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY COUNTRY, 2016-2023 ($MILLION)
TABLE 99. LAMEA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 100. LAMEA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY PRODUCT, 2016-2023 ($MILLION)
TABLE 101. LAMEA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY APPLICATION, 2016-2023 ($MILLION)
TABLE 102. LAMEA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 103. BRAZIL POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 105. BRAZIL POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY APPLICATION, 2016-2023 ($MILLION)
TABLE 106. BRAZIL POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 107. SAUDI ARABIA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 109. SAUDI ARABIA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY APPLICATION, 2016-2023 ($MILLION)
TABLE 110. SAUDI ARABIA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY END USERS, 2016-2023 ($MILLION)
TABLE 111. SOUTH AFRICA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 113. SOUTH AFRICA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY APPLICATION, 2016-2023 ($MILLION)
TABLE 114. SOUTH AFRICA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY END USERS, 2016-2023 ($MILLION)
TABLE 115. REST OF LAMEA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 117. REST OF LAMEA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY APPLICATION, 2016-2023 ($MILLION)
TABLE 118. REST OF LAMEA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,  BY END USERS, 2016-2023 ($MILLION)
TABLE 119. AGILENT: COMPANY SNAPSHOT
TABLE 120. AGILENT: OPERATING SEGMENTS
TABLE 121. AGILENT: PRODUCT PORTFOLIO
TABLE 122. BIOMERIEUX S.A: COMPANY SNAPSHOT
TABLE 123. BIOMERIEUX S.A: OPERATING SEGMENTS
TABLE 124. BIOMERIEUX S.A: PRODUCT PORTFOLIO
TABLE 125. BIO-RAD: COMPANY SNAPSHOT
TABLE 126. BIO-RAD: OPERATING SEGMENTS
TABLE 127. BIO-RAD: PRODUCT PORTFOLIO
TABLE 128. ROCHE: COMPANY SNAPSHOT
TABLE 129. ROCHE: OPERATING SEGMENTS
TABLE 130. ROCHE: PRODUCT PORTFOLIO
TABLE 131. FLUIDIGM: COMPANY SNAPSHOT
TABLE 132. FLUIDIGM: PRODUCT PORTFOLIO
TABLE 133. LGC: COMPANY SNAPSHOT
TABLE 134. LGC: OPERATING SEGMENTS
TABLE 135. LGC: PRODUCT PORTFOLIO
TABLE 136. QIAGEN: COMPANY SNAPSHOT
TABLE 137. QIAGEN: OPERATING SEGMENTS
TABLE 138. QIAGEN: PRODUCT PORTFOLIO
TABLE 139. SYGNIS: COMPANY SNAPSHOT
TABLE 140. SYGNIS: PRODUCT PORTFOLIO
TABLE 141. TAKARA: COMPANY SNAPSHOT
TABLE 142. TAKARA: OPERATING SEGMENTS
TABLE 143. TAKARA: PRODUCT PORTFOLIO
TABLE 144. THERMO FISHER: COMPANY SNAPSHOT
TABLE 145. THERMO FISHER: OPERATING SEGMENTS
TABLE 146. THERMO FISHER: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 1. SEGMENTATION OF GLOBAL POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET
FIGURE 2. TOP WINNING STRATEGIES, BY YEAR, 2014-2017*
FIGURE 3. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2014-2017* (%)
FIGURE 4. TOP WINNING STRATEGIES, BY COMPANY, 2002-2016*
FIGURE 5. TOP INVESTMENT POCKETS, BY PRODUCT, 2016
FIGURE 6. MARKET SHARE ANALYSIS, 2016
FIGURE 7. BARGAINING POWER OF BUYERS
FIGURE 8. BARGAINING POWER OF SUPPLIERS
FIGURE 9. THREAT OF NEW ENTRANTS
FIGURE 10. THREAT OF SUBSTITUTION
FIGURE 11. COMPETITIVE RIVALRY
FIGURE 12. RESTRAINTS AND DRIVERS: GLOBAL POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET
FIGURE 13. AGILENT: NET SALES, 2014-2016 ($MILLION)
FIGURE 14. AGILENT: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 15. AGILENT: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 16. BIOMERIEUX S.A: NET SALES, 2014-2016 ($MILLION)
FIGURE 17. BIOMERIEUX S.A: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 18. BIOMERIEUX S.A: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 19. BIO-RAD: NET SALES, 2014-2016 ($MILLION)
FIGURE 20. BIO-RAD: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 21. BIO-RAD: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 22. ROCHE: NET SALES, 2014-2016 ($MILLION)
FIGURE 23. ROCHE: REVENUE SHARE BY PRODUCT, 2016 (%)
FIGURE 24. ROCHE: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 25. FLUIDIGM: NET SALES, 2014-2016 ($MILLION)
FIGURE 26. FLUIDIGM: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 27. QIAGEN: NET SALES, 2014-2016 ($MILLION)
FIGURE 28. QIAGEN: REVENUE SHARE BY CUSTOMER CLASSES, 2016 (%)
FIGURE 29. QIAGEN: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 30. SYGNIS: NET SALES, 2014-2016 ($MILLION)
FIGURE 31. SYGNIS: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 32. TAKARA: NET SALES, 2014-2016 ($MILLION)
FIGURE 33. TAKARA: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 34. TAKARA: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 35. THERMO FISHER: NET SALES, 2014-2016 ($MILLION)
FIGURE 36. THERMO FISHER: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 37. THERMO FISHER: REVENUE SHARE BY GEOGRAPHY, 2016 (%)

 

Polymerase chain reaction (PCR) is one of the revolutionary technology that was earlier used in research institutions, pharmaceutical, and biotechnology industries. However, due to the advancement in technology, PCR can help to precisely diagnoses life-threatening diseases such as cancer and Ebola, which boosts the popularity and usage of PCR in the commercial diagnostic laboratories and hospitals.

The market is expected to observe a steady growth owing to the expansion in its application areas and increased accuracy and precision. Moreover, the advantages of using PCR technologies such as digital PCR (dPCR) and real-time PCR (qPCR) such as real-time process monitoring, low reagent consumption, automation of workflow, and greater reproducibility and precision. There is a rise in the number of acquisition of standalone laboratories with minimal infrastructure in less developed areas by multi-chain diagnostic laboratories due to the expected increase in the demand for diagnostics techniques in these regions. There is a strong demand for compact and portable PCR with high reliability and sensitivity along with high affordability. These advanced features help provide lucrative growth opportunities for PCR market.

Among the technology segment, dPCR is the fastest-growing segment in the market. The segment is expected to witness the highest CAGR during the forecast period due to the increase in government and private funding for gene-based research, the development of innovative dPCR devices, and high growth opportunities in emerging countries.

The employment of polymerase chain reaction technologies is highest in North America, owing of the increase in funding for the R&D activities, high prevalence rate of chronic diseases, and increase in disposable income among customers. Although the use of polymerase chain reaction technologies in Asia-Pacific and LAMEA region is low, the adoption rate is expected to increase owing to rise in disposable income, rise in incidence rate of chronic diseases, and government initiative to improve healthcare infrastructure is expected to contribute toward the market growth.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Polymerase Chain Reaction Technologies Market

  • Online Only
  • $3690
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $4099
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $4999
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6004
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8373
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo